实用肝脏病杂志
實用肝髒病雜誌
실용간장병잡지
JOURNAL OF CLINICAL HEPATOLOGY
2014年
1期
30-33
,共4页
赵斐%谢萍%姜佳丽%张令强%安威%展玉涛
趙斐%謝萍%薑佳麗%張令彊%安威%展玉濤
조비%사평%강가려%장령강%안위%전옥도
HepG2细胞%他莫昔芬%脂肪变%甘油三酯%脂肪酸合成
HepG2細胞%他莫昔芬%脂肪變%甘油三酯%脂肪痠閤成
HepG2세포%타막석분%지방변%감유삼지%지방산합성
HepG 2 cells%Tamoxifen%Steatosis%Triglyceride%Fatty acid synthesis
目的:研究他莫昔芬(TAM)对体外培养的HepG2细胞脂肪变性以及脂类代谢调控关键因子表达的影响。方法应用油酸(50μmol/L)处理HepG2细胞,诱导细胞脂肪变性体外模型,同时给予不同浓度的TAM (5~20μmol/L)干预72 h;采用油红O染色和甘油三酯含量测定检测HepG2细胞内脂质聚集情况;应用蛋白印迹法检测固醇调节元件结合蛋白-1c(SREBP-1c)、脂肪酸合成酶(FAS)、硬脂酰辅酶A去饱和酶(SCD)、肉酯软脂酰基转移酶(CPT1)和微粒体甘油三酯转移蛋白(MTP)的表达;采用细胞活性检测试剂盒测定细胞活性。结果在干预72 h后,模型组细胞内甘油三酯含量为(16.53±0.17) mg/100 mg蛋白质,在5μmol/L TAM处理细胞内甘油三酯含量为(17.77±0.05) mg/100mg蛋白质,与模型组无显著性差异,但在10μmol/L和20μmol/L TAM处理组较模型组分别增加了31%[(21.57±0.16) mg/100 mg蛋白质]和44%[(23.82±0.44) mg/100 mg蛋白质],(P<0.05);TAM上调细胞内SREBP-1c、FAS、SCD和MTP蛋白表达,但并不改变CPT1蛋白表达;TAM在5~20μmol/L范围内不影响HepG2细胞活性。结论 TAM可促进油酸诱导的HepG2细胞脂肪变性,其主要机制可能是通过上调SREBP-1c及其下游基因,如FAS和SCD的表达而增加了脂肪酸的合成。
目的:研究他莫昔芬(TAM)對體外培養的HepG2細胞脂肪變性以及脂類代謝調控關鍵因子錶達的影響。方法應用油痠(50μmol/L)處理HepG2細胞,誘導細胞脂肪變性體外模型,同時給予不同濃度的TAM (5~20μmol/L)榦預72 h;採用油紅O染色和甘油三酯含量測定檢測HepG2細胞內脂質聚集情況;應用蛋白印跡法檢測固醇調節元件結閤蛋白-1c(SREBP-1c)、脂肪痠閤成酶(FAS)、硬脂酰輔酶A去飽和酶(SCD)、肉酯軟脂酰基轉移酶(CPT1)和微粒體甘油三酯轉移蛋白(MTP)的錶達;採用細胞活性檢測試劑盒測定細胞活性。結果在榦預72 h後,模型組細胞內甘油三酯含量為(16.53±0.17) mg/100 mg蛋白質,在5μmol/L TAM處理細胞內甘油三酯含量為(17.77±0.05) mg/100mg蛋白質,與模型組無顯著性差異,但在10μmol/L和20μmol/L TAM處理組較模型組分彆增加瞭31%[(21.57±0.16) mg/100 mg蛋白質]和44%[(23.82±0.44) mg/100 mg蛋白質],(P<0.05);TAM上調細胞內SREBP-1c、FAS、SCD和MTP蛋白錶達,但併不改變CPT1蛋白錶達;TAM在5~20μmol/L範圍內不影響HepG2細胞活性。結論 TAM可促進油痠誘導的HepG2細胞脂肪變性,其主要機製可能是通過上調SREBP-1c及其下遊基因,如FAS和SCD的錶達而增加瞭脂肪痠的閤成。
목적:연구타막석분(TAM)대체외배양적HepG2세포지방변성이급지류대사조공관건인자표체적영향。방법응용유산(50μmol/L)처리HepG2세포,유도세포지방변성체외모형,동시급여불동농도적TAM (5~20μmol/L)간예72 h;채용유홍O염색화감유삼지함량측정검측HepG2세포내지질취집정황;응용단백인적법검측고순조절원건결합단백-1c(SREBP-1c)、지방산합성매(FAS)、경지선보매A거포화매(SCD)、육지연지선기전이매(CPT1)화미립체감유삼지전이단백(MTP)적표체;채용세포활성검측시제합측정세포활성。결과재간예72 h후,모형조세포내감유삼지함량위(16.53±0.17) mg/100 mg단백질,재5μmol/L TAM처리세포내감유삼지함량위(17.77±0.05) mg/100mg단백질,여모형조무현저성차이,단재10μmol/L화20μmol/L TAM처리조교모형조분별증가료31%[(21.57±0.16) mg/100 mg단백질]화44%[(23.82±0.44) mg/100 mg단백질],(P<0.05);TAM상조세포내SREBP-1c、FAS、SCD화MTP단백표체,단병불개변CPT1단백표체;TAM재5~20μmol/L범위내불영향HepG2세포활성。결론 TAM가촉진유산유도적HepG2세포지방변성,기주요궤제가능시통과상조SREBP-1c급기하유기인,여FAS화SCD적표체이증가료지방산적합성。
Objective To investigate the effect of tamoxifen(TAM) on steatosis in HepG2 cells in vitro and on the expression of key regulators involved in lipid metabolism in the cells. Methods A cell model of steatosis was induced in HepG2 cells in vitro with oleic acid (OA) at 50 μmol/L;HepG2 cells were then subjected to dif-ferent concentrations of TAM (5 to 20 μmol/L) at the presence of OA for 72 h;Intracellular lipid accumulation was assessed by oil red O staining and measurement of triglyceride;The expression of sterol regulatory element-binding protein-1c(SREBP-1c),fatty acid synthase(FAS),steroyl-CoA desaturase(SCD),carnitine palmitoyltrans-ferase 1(CPT1)and mitochondrial trifunctional protein(MTP)was determined by Western blot;Cell viability was de-tected by cell counting Kit-8 assay. Results After incubation for 72 h,the intracellular triglyceride in control group was (16.53±0.17) mg/100 mg protein,similar to that of cells treated with 5μmol/L TAM,however,the intra-cellular triglyceride was increased by 31%[(21.57±0.16) mg/100 mg protein] and 44%[(23.82±0.44) mg/100 mg protein] in cells treated with 10 μmol/L and 20 μmol/L of TAM,respectively(P<0.05);TAM treatment(5 to 10 μmol/L) significantly increased the expression of SREBP-1c,FAS,SCD and MTP without affecting the expression of carni-tine palmitoyltransferase 1 (CPT1) in HepG2 cells;TAM did not affect HepG2 viability. Conclusions TAM pro-motes OA-induced cell steatosis,probably by up-regulation of SREBP-1c,FAS and SCD,thus increases fatty acid synthesis in the cells.